Cutaneous malignant melanoma in Southern Sweden 1965, 1975, and 1985: Prognostic factors and histologic correlations

Cancer

Volumn 79, Issue 2, 1997, Pages 275-283

  Måsbäck, Anna ^a   Westerdahl, Johan ^a   Ingvar, Christian ^a   Olsson, Håkan ^a   Jonsson, Nils ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

age; epidemiology; gender; melanoma; multivariate analysis; pathology; population based; survival; tumor thickness; ulceration

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER SURVIVAL; FEMALE; GENDER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; NEVUS CELL; ONSET AGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SKIN ULCER; SWEDEN;

ADULT; AGE FACTORS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SEX FACTORS; SKIN NEOPLASMS; SURVIVAL ANALYSIS; SWEDEN;

EID: 1842417176     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970115)79:2<275::AID-CNCR11>3.0.CO;2-Y     Document Type: Article

References (35)

1. Devesa SS, Silverman DT, Young LJ Jr., Pollack ES, Brown CC, Horm JW, et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 1987;79:701-70.
2. Magnus K. The Nordic Profile of skin cancer incidence:a comparative epidemiological study of the three main type of skin cancers. Int J Cancer 1991;47:12-9.
3. Magnus K. Incidence of malignant melanoma of the skin in the five Nordic countries:significance of solar radiation. Int J Cancer 1977;20:477-85.
4. McLeod GR, Davies NC, Little JH, Greene A, Chent D. Melanoma in Queensland, Australia:experience of the Queensland Melanoma Project. In: Balch CM, Milton GW, editors. Cutaneous melanoma:clinical management and treatment results worldwide. 1st edition. Philadelphia: J.B. Lippincott, 1985:379-89.
5. Cancer incidence in Sweden 1988. National Board of Health and Welfare. The Cancer Registry. Allmänna förlaget, Stockholm. 1991.
6. Thörn M, Adami H-O, Bergström R, Ringborg U, Krusemo UB. Trends in survival from malignant melanoma:remarkable improvement in 23 years. J Natl Cancer Inst 1989; 81:611-7.
7. Heenan PJ, English DR, Holman CDJ, Armstrong BK. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/75 and 1980/81. Cancer 1991;68:2079-87.
8. Corona R, Sció M, Mele A, Ferranti G, Mostaccilio S, Macchini V, et al. Survival and prognostic factors in patients with localised cutaneous melanoma observed between 1980 and 1991 at the Istituto Dermopatico dell'Immacolata in Rome, Italy. Eur J Cancer 1994;30A:333-8.
9. Thörn M, Pontén F, Bergström R, Sparén P, Adami H-O. Clinical and histopathologic predictors of survival in patients with malignant melanoma:a population-based study in Sweden. J Natl Cancer Inst 1994;86:761-9.
10. Berdeaux DH, Meyskens FL, Parks B, Tong T, Loescher L, Moon TE. Cutaneous malignant melanoma II. The natural history and prognostic factors influencing the development of stage II disease. Cancer 1989;63:1430-6.
11. Balch CM, Soong S-J, Shaw HM, Milton GW. An analysis of prognostic factors in 4000 patients with cutaneous melanoma. In: Balch CM, Milton GW, editors. Cutaneous melanoma:clinical management and tratment results worldwide. 1st edition. Philadelphia: J.B. Lippincott, 1985:321-52.
12. Måsbäck A, Westerdahl J, Ingvar C, Olsson H, Jonsson N. Cutaneous malignant melanoma in South Sweden 1965, 1975, and 1985. A histopathologic review. Cancer 1994; 73:1625-30.
13. McGovern VJ, Mihm MC, Baily C, Booth JC, Clark WH, Cochran AJ, et al. The classification of malignant melanoma and its histological reporting. Cancer 1973;32:1446-57.
14. Clark WH, From L, Bernardino EA, Mihm MC. The histiogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969;29:705-26.
15. Arrington JH III, Reed RJ, Ichinose H, Krementz ET. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1977; 1:131-43.
16. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970;172:902-8.
17. Mattsson B. Cancer registration in Sweden:studies on completeness and validity of incidence and mortality registers [doctoral thesis]. Stockholm: Karolinska Institutet, 1984.
18. Malec E, Eklund G, Lagerlöf B. Re-appraisal of malignant melanoma diagnosis in the Swedish cancer registry. Acta Pathol Microbiol Scanda 1977;85:707-12.
19. Sigurdsson H, Baldetorp B, Borg Å, Dalberg M, Fernö M, Killander D, et al. Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990;322:1045-53.
20. Hakulinen T, Pukkala E, Hakama M, Lehtonen M, Saxén E, Teppo L. Survival of cancer patients in Finland in 1953-1974. Ann Clin Res 1981;13(Suppl 31):69-71.
21. Eldh J, Boeryd B, Peterson LE. Prognostic factors in cutaneous malignant melanoma in stage I. Scand J Plast Reconstr Surg 1978;12:243-55.
22. Drzewiecki KT, Kragh Andersen P. Survival with malignant melanoma. A regression analysis of prognostic factors. Cancer 1982;49:2414-9.
23. Worth AJ, Gallagher RP, Elwood JM, Yang PC, Lamb C, Spinelli JJ, et al. Pathologic prognostic factors for cutaneous malignant melanoma:the Western Canada melanoma study. Int J Cancer 1989;43:370-5.
24. Cascinelli N, Marubini E, Morabito A, Bufalino R. Prognostic factors for Stage I melanoma of the skin:a review. Stat Med 1985;4:265-78.
25. Clark WH, Elder DE, DuPont G, Braitman LE, Trock BJ, Schitz D, et al. Model predicting survival in Stage I melanoma based on tumor progression. J Natl Cancer Inst 1989;81:1893-1904.
26. Shaw HM, McGovern VJ, Milton GW, Farago GA, McCarthy WH. Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer 1980; 45:1604-8.
27. Prade M, Sancho-Garnier H, Cesarini JP, Cochran A. Difficulties encountered in the application of the Clark classification and the Breslow thickness measurement in cutaneous malignant melanoma. Int J Cancer 1980;26:159-63.
28. Heenan PJ, Matz LR, Blackwell JB, Kelsall GRH, Singh A, Ten Seldam REJ, et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in Western Australia. Histopathology 1984;8:717-29.
29. Balch CM, Wilkerson JA, Murad TM, Soong S-J, Ingalls AL, Maddox WA. The prognostic significance of ulceration of cutaneous melanoma. Cancer 1980;45:3012-7.
30. Månsson-Brahme E, Carstensen J, Erhardt K, Lagerlöf B, Ringborg U, Rutqvist LE. Prognostic factors in thin cutaneous malignant melanoma. Cancer 1994;73:2324-32.
31. Gromet MA, Epstein WL, Blois MS. The regressing thin malignant melanoma. A distinctive lesion with metastatic potential. Cancer 1978;42:2282-92.
32. Söndergaard K, Schou G. Survival with primary cutaneous malignant melanoma, evaluated from 2012 cases. Virchows Arch A Pathol Anat Histopathol 1985;406:179-95.
33. Ronan SG, Eng AM, Briele HA, Shioura NN, Das Gupta TK. Thin malignant melanomas with regression and metastases. Arch Dermatol 1987;123:1326-30.
34. Czarnetzki BM, Denter M, Bröcker EB, Rümke P, Krieg V, Vakilzadeh F, et al. Clinical features of superficial spreading melanomas with zones of regression. J Cancer Res Clin Oncol 1984;107:225-8.
35. Nicholls EM. Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma. Cancer 1973;32:191-5.